Articles from OrthoPediatrics Corp.

WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division.
By OrthoPediatrics Corp. · Via GlobeNewswire · January 22, 2025

Achieves all-time high full year 2024 Revenue of $205 million representing growth of 38% Year-Over-YearInitiates guidance for record adjusted EBITDA in 2025
By OrthoPediatrics Corp. · Via GlobeNewswire · January 13, 2025

WARSAW, Ind., Jan. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the rapid expansion of its Specialty Bracing (OPSB) division with entrance into 3 target markets within Indiana, Colorado, and Florida.
By OrthoPediatrics Corp. · Via GlobeNewswire · January 10, 2025

WARSAW, Ind., Dec. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics today announced that the OrthoPediatrics Specialty Bracing (OPSB™) division is expanding its product offering with the launch of two new products including the OPSB Sensor System and MOVE-D™.
By OrthoPediatrics Corp. · Via GlobeNewswire · December 5, 2024

Continues IPOS Corporate Partnership as Emerald-Level Sponsor
By OrthoPediatrics Corp. · Via GlobeNewswire · December 2, 2024

WARSAW, Ind., Nov. 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company dedicated exclusively to advancing the field of pediatric orthopedics, is excited to announce significant updates to the DF2® Brace, a cornerstone product within the OrthoPediatrics Specialty Bracing business (“OPSB”). The DF2 Brace updates include expanded indications for use, enhanced sizing options, and additional international markets.
By OrthoPediatrics Corp. · Via GlobeNewswire · November 26, 2024

WARSAW, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer is scheduled to participate in a fireside chat at two upcoming investor conferences being held in New York, NY.
By OrthoPediatrics Corp. · Via GlobeNewswire · November 12, 2024

Record Third Quarter 2024 Revenue Increased 37% Year-over-Year
By OrthoPediatrics Corp. · Via GlobeNewswire · November 6, 2024

WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2024 financial results on Wednesday, November 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Thursday, November 7, 2024, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · October 23, 2024

Additional details to be discussed during the Company’s Investor Day today, September 12, 2024
By OrthoPediatrics Corp. · Via GlobeNewswire · September 12, 2024

WARSAW, Ind., Aug. 20, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host an investor day at 10:30am E.T. on September 12, 2024, in New York, New York. Management’s presentation will provide updates on the Company’s Specialty Bracing business strategy, product pipeline, and financial outlook and feature a KOL surgeon panel.
By OrthoPediatrics Corp. · Via GlobeNewswire · August 20, 2024

Record Second Quarter 2024 Revenue Increased 33% Year-over-Year
By OrthoPediatrics Corp. · Via GlobeNewswire · August 5, 2024

Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital
By OrthoPediatrics Corp. · Via GlobeNewswire · August 5, 2024

WARSAW, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2024 financial results on Monday, August 5, 2024, after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 6, 2024, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · July 22, 2024

WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer is scheduled to participate in a fireside chat at the Truist Securities MedTech Conference, being held in Boston, MA.
By OrthoPediatrics Corp. · Via GlobeNewswire · June 4, 2024

Reinforced Long-Term Commitment as Emerald Sponsor
By OrthoPediatrics Corp. · Via GlobeNewswire · May 15, 2024

First Quarter 2024 Revenue Increased 41% Year-over-Year
By OrthoPediatrics Corp. · Via GlobeNewswire · May 6, 2024

WARSAW, Ind., May 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has received the “Breakthrough Device” Designation from the Food and Drug Administration (“FDA”) for its new eLLi surgical device, an implant designed to address severe pathology associated with Early Onset Scoliosis (EOS), which can be associated with thoracic insufficiency, a potentially life-threatening condition. eLLi aims to provide a non-invasive means of extending the growing rods that provides increased force, enhanced mechanical reliability, and superior distraction precision, while also addressing safety concerns associated with current technology. eLLi will allow surgeons a new alternative to address deformity of the growing spine with an advanced technology that will complement our efforts to build a platform of EOS technologies. We are proud to have an expert design team comprised of surgeons who have dedicated their careers to treating these unique patients.
By OrthoPediatrics Corp. · Via GlobeNewswire · May 2, 2024

WARSAW, Ind., April 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2024 financial results on Monday, May 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Tuesday, May 7, 2024, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · April 22, 2024

WARSAW, Ind., April 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 8th Annual International Children’s Spine Symposium (ICSS), which will take place April 5th and 6th in Denver, Colorado. The meeting, put on by the Armstrong Children’s Orthopedic Alliance, offers a comprehensive program of lectures given by an outstanding, international faculty and cadaver labs centered on the cervical spine, lumbo-sacral junction, neuromonitoring, and various aspects of scoliosis.
By OrthoPediatrics Corp. · Via GlobeNewswire · April 4, 2024

WARSAW, Ind., March 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference.
By OrthoPediatrics Corp. · Via GlobeNewswire · March 26, 2024

Record full year 2023 revenue of $148.7 million increased 22% compared to prior year
By OrthoPediatrics Corp. · Via GlobeNewswire · March 6, 2024

WARSAW, Ind., March 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has launched a new RESPONSE™ Rib and Pelvic Fixation system to treat children with Early Onset Scoliosis (“EOS”). This represents the company’s 71st system to treat orthopedic conditions in pediatric patients.
By OrthoPediatrics Corp. · Via GlobeNewswire · March 4, 2024

WARSAW, Ind., Feb. 28, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was recently named one of the 2024 Best Places to Work in Indiana. This is the 8th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce.
By OrthoPediatrics Corp. · Via GlobeNewswire · February 28, 2024

WARSAW, Ind., Feb. 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2023 financial results on Wednesday, March 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Thursday, March 7, 2024, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · February 22, 2024

Issues 2024 financial guidance
By OrthoPediatrics Corp. · Via GlobeNewswire · January 8, 2024

Combined organizations have helped more than 1 million kids
By OrthoPediatrics Corp. · Via GlobeNewswire · January 8, 2024

WARSAW, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics. The OrthoPediatrics Specialty Bracing division (“OPSB”) will serve as a flagship house of brands and innovative products that expand the Company’s Total Addressable Market by approximately $600 million.
By OrthoPediatrics Corp. · Via GlobeNewswire · December 6, 2023

Increases IPOS Corporate Partnership as Emerald-Level Sponsor
By OrthoPediatrics Corp. · Via GlobeNewswire · December 4, 2023

WARSAW, Ind., Nov. 09, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer and Chief Financial Officer, are scheduled to participate in fireside chats at two upcoming investor conferences.
By OrthoPediatrics Corp. · Via GlobeNewswire · November 9, 2023

Record Setting Quarterly Revenue of $40.0 million
By OrthoPediatrics Corp. · Via GlobeNewswire · November 6, 2023

WARSAW, Ind., Nov. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the Company has entered into an exclusive Distribution Agreement with Ora Medical, based in Montreal, to sell Ora Medical’s gait trainer, The Levity, a device designed for children with walking difficulties.
By OrthoPediatrics Corp. · Via GlobeNewswire · November 6, 2023

WARSAW, Ind., Nov. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the limited release of the Mitchell Ponseti Plus Bar (“MP+”) as part of their Specialty Bracing portfolio for kids with clubfoot. The new MP+ Bar features several innovations from their traditional Bar, which was originally launched in 2004. These enhancements include:
By OrthoPediatrics Corp. · Via GlobeNewswire · November 1, 2023

WARSAW, Ind., Oct. 19, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has released the new Pediatric Nailing Platform TIBIA system and successfully completed the first cases in its limited launch. The Company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the system in September 2023.
By OrthoPediatrics Corp. · Via GlobeNewswire · October 19, 2023

WARSAW, Ind., Oct. 17, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2023 financial results on Monday, November 6, 2023, after the market closes. OrthoPediatrics will host a conference call on Tuesday, November 7, 2023, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · October 17, 2023

WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, has announced a strategic partnership with Children’s National Hospital in Washington, DC under the “Alliance for Pediatric Device Innovation” (APDI), to advice the development and commercialization of medical devices designed for children.
By OrthoPediatrics Corp. · Via GlobeNewswire · October 12, 2023

WARSAW, Ind., Oct. 10, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the limited release of the DF2® Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries.
By OrthoPediatrics Corp. · Via GlobeNewswire · October 10, 2023

WARSAW, Ind., Sept. 25, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, OrthoPediatrics was a proud sponsor of the 58th Annual Meeting for the Scoliosis Research Society held in Seattle, Washington, on September 6-9th. The Scoliosis Research Society (“SRS”) is an international organization dedicated to the education, research and treatment of Spinal Deformity. This surgical society, and its Annual Meeting are directly aligned with OrthoPediatrics’ cause of helping children with pediatric orthopedic conditions. Our sponsorship of the premiere event represented our on-going commitment to the training and education of our clinical partners, as well as a tremendous learning opportunity for how our organization can better service the unique needs of Pediatric Orthopedic Surgeons and patients with scoliosis.
By OrthoPediatrics Corp. · Via GlobeNewswire · September 25, 2023

WARSAW, Ind., Sept. 14, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer and Chief Financial Officer, are scheduled to participate in a fireside chat at the upcoming Gilmartin Group Emerging Growth Company Showcase on Thursday, September 21, 2023.
By OrthoPediatrics Corp. · Via GlobeNewswire · September 14, 2023

WARSAW, Ind., Sept. 11, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Pediatric Nailing Platform | Tibia (“PNP Tibia”) surgical system.
By OrthoPediatrics Corp. · Via GlobeNewswire · September 11, 2023

Record Setting Quarterly Revenue of $39.6 million
By OrthoPediatrics Corp. · Via GlobeNewswire · July 31, 2023

WARSAW, Ind., July 18, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2023 financial results on Monday, July 31st, 2023, after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 1, 2023, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · July 18, 2023

WARSAW, Ind., June 27, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the limited launch and the completion of the first clinical case using the new GIRO Growth Modulation System.
By OrthoPediatrics Corp. · Via GlobeNewswire · June 27, 2023

WARSAW, Ind., June 15, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that George Dyer, MD was elected to the Company’s Board of Directors at its Annual Meeting of Stockholders held on June 14, 2023.
By OrthoPediatrics Corp. · Via GlobeNewswire · June 15, 2023

WARSAW, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced the launch of their new Power System for the RESPONSE™ Scoliosis portfolio. The RESPONSE Power System is a complete portfolio of instruments for tapping pedicles, inserting screws, and final tightening of set screws. RESPONSE Power is compatible with OrthoPediatrics’ entire suite of fusion implant systems, including RESPONSE 4.5/5.0and RESPONSE 5.5/6.0 fusion systems, and BandLoc – a sublaminar banding technology. This represents the company’s 49th system for pediatric orthopedic care.
By OrthoPediatrics Corp. · Via GlobeNewswire · May 4, 2023

First Quarter 2023 Revenue Increased 35% Year-over-Year
By OrthoPediatrics Corp. · Via GlobeNewswire · May 1, 2023

Establishes Longer-term Commitment as an Emerald Sponsor
By OrthoPediatrics Corp. · Via GlobeNewswire · May 1, 2023

WARSAW, Ind., April 20, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced the release of its new Cannulated Screw System for the RESPONSE™ Scoliosis portfolio. The RESPONSE 5.5/6.0 Cannulated Screw system is a complete portfolio of instruments and implants and represents the Company’s 47th surgical system and it’s continued commitment to leading innovation in pediatric orthopedics.
By OrthoPediatrics Corp. · Via GlobeNewswire · April 20, 2023

WARSAW, Ind., April 17, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2023 financial results on Monday, May 1, 2023, after the market closes. OrthoPediatrics will host a conference call on Tuesday, May 2, 2023, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · April 17, 2023

WARSAW, Ind., April 03, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer and Chief Financial Officer, are scheduled to participate in a fireside chat at the upcoming 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2023.
By OrthoPediatrics Corp. · Via GlobeNewswire · April 3, 2023

WARSAW, Ind., March 31, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced its leading sponsorship at the European Pediatric Orthopaedic Society (“EPOS”) annual meeting in Krakow, Poland. The company hosted an exhibit for OrthoPediatrics, Pega Medical, and MD Orthopaedics as well as a surgeon luncheon.
By OrthoPediatrics Corp. · Via GlobeNewswire · March 31, 2023

WARSAW, Ind., March 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was recently named one of the 2023 Best Places to Work in Indiana. This is the 7th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce. Due to the Company’s growth in recent years, they are now listed in the “Large Employer” category.
By OrthoPediatrics Corp. · Via GlobeNewswire · March 6, 2023

Fourth Quarter 2022 Revenue Increased 25% Year-over-YearFull Year 2022 Revenue Increased 25% Year-over-Year
By OrthoPediatrics Corp. · Via GlobeNewswire · February 28, 2023

WARSAW, Ind., Feb. 14, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2022 financial results on Tuesday, February 28, 2023, after the market closes. OrthoPediatrics will host a conference call on Wednesday, March 1, 2023, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · February 14, 2023

WARSAW, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the publication of an Environmental, Social, and Governance (“ESG”) summary report. The report highlights how the Company’s commitment to diversity, inclusion and ethics underscores its mission to transform the lives of children with orthopedic conditions and provides a baseline of key ESG performance metrics.
By OrthoPediatrics Corp. · Via GlobeNewswire · February 1, 2023

WARSAW, Ind., Jan. 09, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2022, and provided 2023 financial guidance.
By OrthoPediatrics Corp. · Via GlobeNewswire · January 9, 2023

WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of its direct sales organization in Germany. OrthoPediatrics GmbH, commencing operations on January 1, 2023. OrthoPediatrics’ first direct international organization represents an expanding commitment to support pediatric orthopedics in international markets.
By OrthoPediatrics Corp. · Via GlobeNewswire · January 6, 2023

Continues IPOS Corporate Partnership as Double Diamond Sponsor
By OrthoPediatrics Corp. · Via GlobeNewswire · December 5, 2022

WARSAW, Ind., Nov. 04, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer and Chief Financial Officer, are scheduled to participate in fireside chats at two upcoming investor conferences.
By OrthoPediatrics Corp. · Via GlobeNewswire · November 4, 2022

Third Quarter 2022 Record Revenue Increased 39% Year-over-Year
By OrthoPediatrics Corp. · Via GlobeNewswire · October 31, 2022

WARSAW, Ind., Oct. 20, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Jimmy D. McDonald to its board of directors, effective October 18, 2022.
By OrthoPediatrics Corp. · Via GlobeNewswire · October 20, 2022

WARSAW, Ind., Oct. 18, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQKIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2022 financial results on Monday, October 31, 2022, after the market closes. OrthoPediatrics will host a conference call on Tuesday, November 1, 2022, at 8:00 a.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · October 18, 2022